Research Linking GLP-1 Medications to NAION Multiple large-scale studies published in 2024-2025 documented alarming associations between semaglutide and dramatically elevated NAION rates
Comparison with Mendelian randomization analyses of body mass index and T2D genetic liability Mendelian randomization analysis was performed to investigate the effect of genetic liability to lower body mass index (BMI) and lower T2D risk on the circulating proteome, using genetic association estimates for circulating proteins from the deCODE cohort
These medications already provide life-changing results for many individuals struggling with weight
I believe we need a clinical trial to determine if semaglutide significantly reduces the risk of arthrofibrosis returning after surgery, beginning treatment before surgery and continuing for three months post-op
Glutathione therapy can support a broader wellness routine, but it is not a substitute for medical care, nutrition, sleep, hydration, or a provider-directed health plan